Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Dorshow

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Toxicology|June 27, 2022
Evaluation of Developmental and Reproductive Toxicity in Rabbits for MB-102, a Fluorescent Tracer Agent Designed for Real-Time Measurement of Glomerular Filtration RateJoseph E Bugaj, Richard B Dorshow
Regulatory Toxicology and Pharmacology : RTP|July 6, 2019
Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rateRichard B Dorshow, Joseph E Bugaj
Regulatory Toxicology and Pharmacology : RTP|March 23, 2022
Absence of developmental or reproductive toxicity in rats for MB-102, a fluorescent tracer agent for point-of-care measurement of glomerular filtration rateJoseph E Bugaj, Richard B Dorshow
Regulatory Toxicology and Pharmacology : RTP|March 3, 2015
Pre-clinical toxicity evaluation of MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rateJoseph E Bugaj, Richard B Dorshow
Journal of Biomedical Optics|May 13, 2018
Transdermal optical renal function monitoring in humans: development, verification, and validation of a prototype deviceMartin P Debreczeny, Richard B Dorshow
American Journal of Veterinary Research|April 29, 2020
Effectiveness of MB-102, a novel fluorescent tracer agent, for conducting ocular angiography in dogsChristopher G Pirie, Thomas E Rogers, Richard B Dorshow
Clinical Kidney Journal|February 19, 2025
CKD stage misclassification between estimated GFR and measured GFR in a clinical study of chronic kidney patientsRichard B Dorshow, Martin P Debreczeny, Stuart L Goldstein
Journal of the American Society of Nephrology : JASN|February 7, 2025
GFR Measurement Using Transdermal Detection MethodologyRichard B Dorshow, Martin P Debreczeny, Stuart L Goldstein
Kidney International|July 4, 2024
Clinical validation of the novel fluorescent glomerular filtration rate tracer agent relmapirazin (MB-102)Richard B Dorshow, Martin P Debreczeny, Stuart L Goldstein, et al.
Applied Optics|February 13, 2013
Mini review of ultrafast fluorescence polarization spectroscopy [invited]Yang Pu, Wubao Wang, Richard B Dorshow, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Toxicology|June 27, 2022
Evaluation of Developmental and Reproductive Toxicity in Rabbits for MB-102, a Fluorescent Tracer Agent Designed for Real-Time Measurement of Glomerular Filtration RateJoseph E Bugaj, Richard B Dorshow
Regulatory Toxicology and Pharmacology : RTP|July 6, 2019
Next tier in vitro and in vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rateRichard B Dorshow, Joseph E Bugaj
Regulatory Toxicology and Pharmacology : RTP|March 23, 2022
Absence of developmental or reproductive toxicity in rats for MB-102, a fluorescent tracer agent for point-of-care measurement of glomerular filtration rateJoseph E Bugaj, Richard B Dorshow
Regulatory Toxicology and Pharmacology : RTP|March 3, 2015
Pre-clinical toxicity evaluation of MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rateJoseph E Bugaj, Richard B Dorshow
Journal of Biomedical Optics|May 13, 2018
Transdermal optical renal function monitoring in humans: development, verification, and validation of a prototype deviceMartin P Debreczeny, Richard B Dorshow
American Journal of Veterinary Research|April 29, 2020
Effectiveness of MB-102, a novel fluorescent tracer agent, for conducting ocular angiography in dogsChristopher G Pirie, Thomas E Rogers, Richard B Dorshow
Clinical Kidney Journal|February 19, 2025
CKD stage misclassification between estimated GFR and measured GFR in a clinical study of chronic kidney patientsRichard B Dorshow, Martin P Debreczeny, Stuart L Goldstein
Journal of the American Society of Nephrology : JASN|February 7, 2025
GFR Measurement Using Transdermal Detection MethodologyRichard B Dorshow, Martin P Debreczeny, Stuart L Goldstein
Kidney International|July 4, 2024
Clinical validation of the novel fluorescent glomerular filtration rate tracer agent relmapirazin (MB-102)Richard B Dorshow, Martin P Debreczeny, Stuart L Goldstein, et al.
Applied Optics|February 13, 2013
Mini review of ultrafast fluorescence polarization spectroscopy [invited]Yang Pu, Wubao Wang, Richard B Dorshow, et al.
Pageof 4